Aminoglycosides and metronidazole for people with cirrhosis and hepatic encephalopathy

To assess the benefits and harms of aminoglycosides and metronidazole versus placebo, no intervention, or other pharmacological interventions on mortality, morbidity, and adverse events for people with cirrhosis and hepatic encephalopathy.

This is a protocol.

Share/Save